Showing 31-40 of 66 results for "".
- 2025 AAD: New Technologies for Face and Body Treatmentshttps://modernaesthetics.com/news/2025-aad-new-technologies-for-face-and-body-treatments-1/2473754/Skin tightening, innovations for cellulite and contouring, muscle stimulation methods, and hair restoration technology were the topics of “New Technologies for the Face and Body” presented by Neil Sadick, MD, FACP, FAACS, FACPh, FAAD, during the “Future of Cosmetic Dermatology&r
- Study Explores Improving Neck Laxity, Wrinkle Severityhttps://modernaesthetics.com/news/ma-chief-medical-editor-leads-study-to-improve-neck-laxity-wrinkle-severity/2473621/A new case study published in Cureus by Saami Khalifian, MD; Alec D. McCarthy, MD; and Steven Yoelin, MD, investigates the efficacy and safety of an injectable therapy to treat neck wrinkles and skin laxity by utilizing a combination of hyperdiluted calcium hydroxylapatite (CaHA), platelet-r
- Highlights From IMCAS World Congress 2024: 25 years at the Forefront of Medical Aesthetics and Countinghttps://modernaesthetics.com/news/highlights-from-imcas-world-congress-2024-25-years-at-the-forefront-of-medical-aesthetics-and-counting-1/2473561/As a veteran of the International Master Course on Aging Science (IMCAS) for over two decades, IMCAS 2024 was the largest congress to date with over 18,000 attendees in the Palais des Congres. Located in central Paris, we had to navigate a construction zone as workmen were busy getting the city r
- L'Oréal USA to Open New Research & Innovation Center in New Jerseyhttps://modernaesthetics.com/news/loreal-usa-to-open-new-research-innovation-center-in-new-jersey/2473305/L'Oréal USA is opening a new, state-of-the-art Research & Innovation (R&I) Center in Clark, New Jersey, replacing its existing facilities that it has occupied in the area for more than six decades. The $140 million development project represents the most significant investment
- Trend Alert: New Allergan Aesthetics Report Highlights What’s to Comehttps://modernaesthetics.com/news/trend-alert-new-allergan-aesthetics-report-highlights-whats-to-come/2473254/Consumer interest in medical aesthetics continues to rise, with the number of dermal filler treatments worldwide growing by almost two million between 2017 and 2020, according to Allergan Aesthetics’ 'The Future of Aesthetics' global trends report. In addition, the r
- Newsweek OpEd: Senator, Modern Aesthetics® Magazine Contributor Address "No Surprises Act"https://modernaesthetics.com/news/newsweek-oped-senator-modern-aesthetics-magazine-contributor-address-no-surprises-act/2473207/Although surprise bills are one of the biggest drivers of medical bankruptcy in America, the "No Surprises Act" (NSA) is being overlooked, say Jonathan Kaplan, MD and Sen. William Cassidy, MD (R, Louisiana) in a new
- Soliton Appoints Aesthetic Executive Veteran Brad Hauser as President and CEO in Preparation for Commercial Launchhttps://modernaesthetics.com/news/soliton-appoints-aesthetic-executive-veteran-brad-hauser-as-president-and-ceo-in-preparation-for-commercial-launch/2473013/Soliton, Inc., has named Brad A. Hauser as President and Chief Executive Officer of Soliton. He most recently served as Vice President, R&D and General Manager for CoolSculpting at Allergan Aesthetics, an AbbVie Company, since Allergan's
- Allergan Buys Luminera Dermal-Filler Businesshttps://modernaesthetics.com/news/allergan-buys-luminera-dermal-filler-business/2473000/Allergan Aesthetics, an AbbVie company, has acquired Luminera's full dermal filler portfolio and R&D pipeline. Luminera is a privately held aesthetics company based in Israel with a portfolio and pipeline of dermal filler products. "
- Coping with COVID-19: Multidisciplinary Panel Offers Procedure-Specific Counsel on Reopening Aesthetic Practiceshttps://modernaesthetics.com/news/coping-with-covid-19-multidisciplinary-panel-offers-procedure-specific-counsel-on-reopening-aesthetic-practices/2472926/Certain minimally invasive aesthetic procedures including those that are lengthy, take place above the clavicle, and are considered aerosol-generating may be riskier than others in the post-COVID-19 world and will require enhanced precautions and a slower integration than procedures deemed less r
- Revance Enters Exclusive Distribution Deal with Teoxane SA for Dermal Fillershttps://modernaesthetics.com/news/revance-enters-exclusive-distribution-deal-with-teoxane-sa-for-dermal-fillers/2472863/With the signing of a new distribution agreement, Revance Therapeutics, Inc. is now the exclusive US commercialization partner of Teoxane SA for its dermal filler products. Revance has immediate and exclusive rights to commercialize Teoxane’s Resilient Hyaluronic Acid® (R